Recombinant hiv-1 Gag p24 protein
The HIV1 p24 protein performs highly complex orchestrated tasks during the assembly, budding maturation and infection stages of the viral replication cycle. During viral assembly, the proteins form membrane associations and self-associations that ultimately result in budding of an immature virion from the infected cell. Gag p24, the major capsid protein of the HIV-1 virion, has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different isolates. Recombinant HIV1-p24 protein, fused to His-tag at N-terminus, was expressed in E. coli and purified by using conventional chromatography.
Product Specifications
Product Name Alternative
Group-specific antigen - p24, CA, Capsid protein p24, Group-specific antigen - p24
Expression System
E.coli
Antigen Species
HIV-1
Tag
His-Tag
Applications
SDS-PAGE
Concentration
0.5 mg/mL (determined by Bradford assay)
Purity
> 80% by SDS-PAGE
Molecular Weight
21.2 kDa (188aa) confirmed by MALDI-TOF
Additionnal Information
References & Citations
Bernard NF., et al. (2009) Clin Immunol. 131 (2) :277-87.; ; Wagstaff M., et al. (1995) Immunology. 86 (1) :85-96.;
Storage Conditions
Can be stored at 2°C to 8°C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
Formulation
Liquid in. 20 mM Tris-HCl buffer (pH 8.0) containing 100 mM NaCl, 0.1mM PMSF, 10% glycerol
Scientific Category
Virus
NCBI Accession Number
AAA44987.1
Uniprot Accession Number
P12493
Species
HIV-1
AA Sequence
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items